INDIA New England News
Varshini Prakash (Photo: Twitter)
BOSTON A panel of nine independent judges on Saturday broke from the tradition and chose 27-year-old climate activist Varshini Prakash as Woman of the Year 2021. Ms. Prakash was on the TIME 100 Next List in 2019 and also made to Forbes magazine’s 30 Under 30 2020.
During the 18
th annual INDIA New England Woman of the Year Awards ceremony virtual this year, judges went for Ms. Prakash’s courage, persistence and energy to inspire to the next generation to join the battle to make the world a better place.
Ms. Prakash is leading a climate revolution in U.S. politics. Co-founder and Executive Director of the Sunrise Movement, as well as co-author of the book “Winning the Green New Deal: Why We Must, How We Can”, Ms. Prakash has led a youth movement to stop climate change and create millions of good jobs in the process, while bringing The Green New Deal to the attention of millions during the recent electio
Meet the Judges for Woman of the Year 2021 - INDIA New England News
indianewengland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indianewengland.com Daily Mail and Mail on Sunday newspapers.
Intravenous Immunoglobulin (IVIG) Market - Global Industry Analysis, Size, Share, Growth, Trends and
briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Search jobs 05-Mar-2021 Multiple Myeloma Drugs Market 2019 Leading Players, SWOT Analysis, Segments, Size, Regional Study and Industry Growth by Forecast to 2026
Global Multiple Myeloma Drugs Market
Multiple Myeloma is a form of cancer formed in a type of white blood cells, known as plasma cells. Malignant tumors originate from highly unstable abnormal cells travelling via the blood stream, circulatory system, and the lymphatic system. In this condition, the plasma cells become cancerous and vigorously proliferative, producing a tumor, called plasmacytoma, which prevents the bone marrow from producing healthy blood cells and immunoglobulins. The formation and proliferation of myeloma cells result in the production of fewer leukocytes, erythrocytes, and platelet cells, causing an impaired immune system. Gastrointestinal problems, enlarged organs, kidney damage, rapid weight loss, bone pain, and fever are some of the common symptoms
Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference
FRAMINGHAM, MA / ACCESSWIRE /
March 3, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ( Xenetic or the Company ), a biopharmaceutical company focused on advancing XCART, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021.
In addition to the presentation, management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website here.